| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.0068 | 1 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.0046 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |